JPRN-UMIN000042064已完成1 期
Phase I/II clinical trial to evaluate the efficacy and safety of DFP-17729 in patients with unresectable/recurrent/progressive pancreatic cancer - Phase I/II clinical trial of DFP-17729
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient without 1)Obvious infection 2)Severe heart diseases 3)Severe complicatios 4)Brain metasitases 5)Severe digestive diseases 6)Severe thromboembolisms 7)Severe diarrhea 8)Severe psychosis 9)Double cancer 10)Pregnant woman/ Breastfeeding 11)Continuous systemic administration of steroids 12)Effects of pretreatment 13)Blood transfusion and blood component preparation 14)Patients judged to be inappropriate
研究者
相似试验
已完成
不适用
A Phase II clinical trial to evaluate the efficacy and safety of intra-arterial infusion chemotherapy for head and neck squamous cell carcinomahead and neck squamous cell carcinomaJPRN-UMIN000019865Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University40
招募中
2 期
Trial evaluating the safety and efficacy of Venetoclax in addition to a standard conditioning regime in patients with certain forms of leukemia undergoing allogeneic blood stem cell transplantation2024-514688-24-00Heinrich-Heine-Universitaet Duesseldorf38
招募中
1 期
Trial evaluating the safety and efficacy of Venetoclax in addition to a standard conditioning regime in patients with certain forms of leukemia undergoing allogeneic blood stem cell transplantatioCTIS2024-514688-24-00Heinrich-Heine-Universitaet Duesseldorf38
进行中（未招募）
1 期
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000810-44-ESFundació Sant Joan de Déu30
进行中（未招募）
不适用
Phase II clinical trial to evaluate the efficacy and safety in the use of pancreatic islets cells from cadaver donors for the treatment of Type-I Diabetes Mellitus in renal transplant patients.Type-I Diabetes Mellitus in renal trasplant patientsMedDRA version: 8.1Level: ptClassification code 10061835EUCTR2005-004523-19-ESÁrea de Trasplante y Terapia Celular - Hospital Central de Asturias10